Recent developments in the therapy of acromegaly

Expert Opinion on Investigational Drugs
Angela N Paisley, Peter Trainer

Abstract

Acromegaly, a condition due to growth hormone hypersecretion usually from a benign pituitary tumour, is associated with significant morbidity and mortality. Disease control leads to normalisation of life expectancy with a reduction in signs and symptoms. Treatment modalities include surgery, radiotherapy and medical management. Surgery is the primary treatment in most of the patients, with success rates of 61-91% reported for those with microadenomas who are operated on by a specialist pituitary surgeon; however, most patients have macroadenomas and, although benefiting from surgery, are not cured and require additional medical therapy. This review will focus on emerging concepts in the medical treatment of acromegaly.

References

Dec 1, 1983·Clinical Endocrinology·P Kendall-TaylorD Cook
Jul 1, 1994·Clinical Endocrinology·C RajasooryaH K Ibbertson
Feb 19, 1998·The Journal of Clinical Endocrinology and Metabolism·R AbsA Beckers
Aug 6, 1999·Frontiers in Neuroendocrinology·Y C Patel
Nov 18, 2000·Pituitary·I M Holdaway, C Rajasoorya
Jan 6, 2001·Pituitary·E M ErfurthL E Hagmar
May 1, 2002·European Journal of Endocrinology·S W J LambertsL J Hofland
Jul 11, 2002·The Journal of Clinical Endocrinology and Metabolism·Pamela U Freda
Aug 30, 2002·Journal of Molecular Endocrinology·S PradhanangaR J M Ross
Sep 6, 2002·The Journal of Clinical Endocrinology and Metabolism·John AyukMichael C Sheppard
Jan 4, 2003·Molecular Endocrinology·Mathias Z StrowskiHilary A Wilkinson
Feb 7, 2004·The Journal of Clinical Endocrinology and Metabolism·Joost van der HoekSteven W Lamberts
Feb 7, 2004·The Journal of Clinical Endocrinology and Metabolism·Omar SerriJules Hardy
Feb 7, 2004·The Journal of Clinical Endocrinology and Metabolism·Ian M HoldawayGreg D Gamble
Sep 2, 2004·European Journal of Endocrinology·A ColaoG Lombardi
Apr 14, 2005·The Journal of Clinical Endocrinology and Metabolism·Shlomo MelmedAriel Barkan
Aug 3, 2005·European Journal of Endocrinology·G M BesserA F Daly

❮ Previous
Next ❯

Citations

Dec 5, 2008·Expert Opinion on Investigational Drugs·Jens BollerslevJens P Berg
Apr 3, 2012·Advanced Drug Delivery Reviews·Cynthia L StevensonRobert Langer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
G VitaleA Colao
Pharmaceutical Research
Esther Eljarrat-BinstockAbraham J Domb
Expert Opinion on Drug Delivery
Frances E KaneKenneth E Green
© 2021 Meta ULC. All rights reserved